Elocom 1mg/g ointment

Country: Арменија

Језик: Енглески

Извор: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активни састојак:

mometasone (mometasone furoate)

Доступно од:

Schering-Plough Labo N.V.

АТЦ код:

D07AC13

INN (Међународно име):

mometasone (mometasone furoate)

Дозирање:

1mg/g

Фармацеутски облик:

ointment

Јединице у пакету:

aluminum tube 15g

Тип рецептора:

Prescription

Статус ауторизације:

Registered

Датум одобрења:

2015-02-20

Карактеристике производа

SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
TRADE NAME: ELOCOM
INTERNATIONAL NONPROPRIETARY NAME:
mometasone
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 g of ointment contains
_active substance:_
1 mg of mometasone furoate;
_excipients:_
hexylene glycol, purified water, phosphoric acid, propylene glycol
stearate, white
beeswax, white vaseline.
3.
PHARMACEUTICAL FORM
Ointment.
_ _
_MAIN PHYSICOCHEMICAL PROPERTIES: _
white or off-white opaque ointment, free of foreign matter.
_PHARMACOTHERAPEUTIC GROUP_.
Corticosteroids for topical use in dermatology. Corticosteroids,
potent (group III).
Code АТС D07A C13
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Topical management of inflammation and pruritic manifestations of
corticosteroid
responsive skin
diseases, including psoriasis and atopic dermatitis
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
A small quantity of Elocom should be applied to the affected areas of
the skin once daily.
Duration of treatment is defined by severity and state of the disease
and should be determined
individually.
Use of topical corticosteroids in children and adults on the face
should not exceed 5 days.
Continuous application of the drug should not exceed 2-3 weeks.
_Children _
Elocom should be used with caution in adults and children over 2
years. There are limited data
on the use of the drug to treat children younger than 2 years.
4.3
CONTRAINDICATIONS
Elocom is contraindicated in patients who are hypersensitive to any
ingredient in the product.
As
other
corticosteroids,
Elocom
is
contraindicated
in
acne
vulgaris,
rosacea,
perioral
dermatitis,
perianal
and
genital
pruritis,
nappy
rash,
bacterial
(for
example,
impetigo,
pyoderma),
viral
(simplex,
herpes
zoster,
varicella,
vulgar
warts,
pointed
condylomas,
molluscum
contagiosum)
and
fungal
(for
example,
caused
by
yeast-like
fungi
and
dermatophytes) skin infections, parasitic infestations, tuberculosis,
syphilis or post-vaccine
reactions.
The product should not be applied to wounds, ulceration, areas of
atrophi